Q32 Bio Inc. — Director's Dealing 2023

Jan 20, 2023

SEC Form 4/A — Form 4/A

Issuer: Homology Medicines, Inc. (FIXX)
CIK: 0001661998
Period of Report: 2023-01-09

Reporting Person: Blum Michael Lee (Chief Commercial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	9408	Direct

Footnotes

F1: This amended Form 4 is being filed to correct the aggregate common stock holdings of the Reporting Person. On each of January 4, 2023 and January 11, 2023, the Reporting Person filed a Form 4 that inadvertently re-reported Employee Stock Purchase Plan ("ESPP") shares that were previously reported. Accordingly, the common stock holdings in column 5 of Table I have been reduced by 630 ESPP shares.